TLDR COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.
A 67-year-old woman with chronic cutaneous lupus erythematosus (CLE) experienced a Rowell syndrome-like flare after a mild COVID-19 infection, presenting with erythematous, scaly, and annular lesions, and erythema multiforme-like lesions. Clinical, histopathologic, and immunofluorescence findings confirmed the diagnosis. Treatment with systemic methylprednisolone and hydroxychloroquine led to significant improvement, and the patient remained in clinical remission for 6 months with maintenance therapy. This case suggests that COVID-19 may exacerbate CLE due to immune responses triggered by the virus.
33 citations
,
June 2021 in “Dermatologic Therapy” COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.
October 2024 in “Reumatizam” New treatments and understanding of skin lupus are emerging in 2024.
157 citations
,
August 2010 in “Lupus” The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.
Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.
3 citations
,
June 2020 in “Open access rheumatology” A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.
11 citations
,
September 2022 in “The Journal of Rheumatology” Skin problems are common in lupus patients and should be treated early to prevent worsening.
research Skin
2 citations
,
January 2011 in “Elsevier eBooks” Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.